Vanguard Group
ALHC icon

Vanguard Group’s Alignment Healthcare ALHC Stock Holding History

Vanguard Group’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$306M Buy
15,492,802
+1,524,218
+11% +$27.4M ﹤0.01% 1327
2025
Q3 		$244M Buy
13,968,584
+664,769
+5% +$9.86M ﹤0.01% 1444
2025
Q2 		$186M Buy
13,303,815
+2,189,919
+20% +$35.3M ﹤0.01% 1537
2025
Q1 		$207M Buy
11,113,896
+1,295,825
+13% +$19.3M ﹤0.01% 1464
2024
Q4 		$110M Buy
9,818,071
+166,837
+2% +$1.95M ﹤0.01% 1829
2024
Q3 		$114M Buy
9,651,234
+60,760
+0.6% +$575K ﹤0.01% 1814
2024
Q2 		$75M Buy
9,590,474
+351,002
+4% +$2.29M ﹤0.01% 1977
2024
Q1 		$45.8M Buy
9,239,472
+93,262
+1% +$597K ﹤0.01% 2213
2023
Q4 		$78.7M Buy
9,146,210
+24,778
+0.3% +$181K ﹤0.01% 1983
2023
Q3 		$63.3M Buy
9,121,432
+322,661
+4% +$1.95M ﹤0.01% 2021
2023
Q2 		$50.6M Buy
8,798,771
+537,383
+7% +$3.47M ﹤0.01% 2178
2023
Q1 		$52.5M Sell
8,261,388
-160,278
-2% -$1.53M ﹤0.01% 2157
2022
Q4 		$99M Buy
8,421,666
+304,273
+4% +$3.7M ﹤0.01% 1812
2022
Q3 		$96.1M Buy
8,117,393
+1,626,831
+25% +$23.7M ﹤0.01% 1810
2022
Q2 		$74.1M Buy
6,490,562
+314,071
+5% +$3.31M ﹤0.01% 1995
2022
Q1 		$69.4M Buy
6,176,491
+50,997
+0.8% +$459K ﹤0.01% 2132
2021
Q4 		$86.1M Buy
6,125,494
+3,631,401
+146% +$63.6M ﹤0.01% 2068
2021
Q3 		$39.9M Sell
2,494,093
-18,689
-0.7% -$361K ﹤0.01% 2487
2021
Q2 		$58.7M Buy
2,512,782
+2,116,624
+534% +$51.5M ﹤0.01% 2280
2021
Q1 		$8.69M Buy
+396,158
New +$7.74M ﹤0.01% 3232

Other funds holding ALHC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group's ALHC Position: Q4 2025 in Review

Vanguard Group increased its Alignment Healthcare (ALHC) stake by 11% in Q4 2025, buying an estimated $27.4M and bringing the position to 15,492,802 shares worth $306M. The position accounts for ﹤0.01% of the portfolio, ranked #1327.

Vanguard Group first reported a position in ALHC in Q1 2021 and has held it in 20 quarters since. 263 funds tracked by Wall St. Rank hold ALHC as of Q4 2025.

  • Vanguard Group held 15,492,802 shares of Alignment Healthcare worth $306M as of Q4 2025.
  • Vanguard Group bought 1,524,218 Alignment Healthcare shares in Q4 2025, an estimated $27.4M.
  • Alignment Healthcare made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1327 holding.
  • Vanguard Group first reported a position in Alignment Healthcare in Q1 2021 and has held it in 20 quarters since.
  • 263 funds tracked by Wall St. Rank held Alignment Healthcare as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.